Dr. Gopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1125 Trenton Harbourton Road
Ewing, NJ 08560Phone+1 609-730-2000
Education & Training
Baylor College of MedicineResidency, Family Medicine, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Surgery, 1995 - 1997
Rutgers Robert Wood Johnson Medical SchoolClass of 1995
Certifications & Licensure
NJ State Medical License 2000 - 2025
Publications & Presentations
PubMed
- 71 citationsPharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.Christoph U. Correll, Edward Kim, Jennifer Kern Sliwa, Wayne Hamm, Srihari Gopal
CNS Drugs. 2021-01-01 - 21 citationsTrajectories and changes in individual items of positive and negative syndrome scale among schizophrenia patients prior to impending relapse.Dai Wang, Srihari Gopal, Susan Baker, Vaibhav A. Narayan
NPJ Schizophrenia. 2018-06-20 - 3 citationsImprovement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority StudySrihari Gopal, Jagadish Gogate, Katalin Pungor, Edward Kim, Arun Singh
Neuropsychiatric Disease and Treatment. 2020-03-06
Journal Articles
- Relapse After Antipsychotic Discontinuation in Schizophrenia as a Withdrawal Phenomenon vs Illness Recurrence:Srihari Gopal, MD, The Journal of Clinical Psychiatry
Press Mentions
Injectable vs Oral Antipsychotics: Which Do Patients Prefer?June 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
